An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the Medicare costs for people with the disease in 2050 by… [ Get More Details ]
Delaying the onset and progression of Alzheimer’s disease would reduce the projected number of people with moderate to severe cases of the disase to 4.4 million instead of 10.3 million… [ Get More Details ]
Early Gene Therapy Studies Show Promise for Parkinson’s Disease
Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs… [ Get More Details ]
The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.
[ Get More Details ]